Literature DB >> 9458975

Myocyte necrosis is the basis for fibrosis in renovascular hypertensive rats.

M P Okoshi1, L S Matsubara, M Franco, A C Cicogna, B B Matsubara.   

Abstract

The pathogenesis of fibrosis and the functional features of pressure overload myocardial hypertrophy are still controversial. The objectives of the present study were to evaluate the function and morphology of the hypertrophied myocardium in renovascular hypertensive (RHT) rats. Male Wistar rats were sacrificed at week 4 (RHT4) and 8 (RHT8) after unilateral renal ischemia (Goldblatt II hypertension model). Normotensive rats were used as controls. Myocardial function was analyzed in isolated papillary muscle preparations, morphological features were defined by light microscopy, and myocardial hydroxyproline concentration (HOP) was determined by spectrophotometry. Renal artery clipping resulted in elevated systolic arterial pressure (RHT4: 178 +/- 19 mmHg and RHT8: 194 +/- 24 mmHg, P < 0.05 vs control: 123 +/- 7 mmHg). Myocardial hypertrophy was observed in both renovascular hypertensive groups. The myocardial HOP concentration was increased in the RHT8 group (control: 2.93 +/- 0.38 micrograms/mg; RHT4: 3.02 +/- 0.40 micrograms/mg; RHT8: 3.44 +/- 0.45 micrograms/mg of dry tissue, P < 0.05 vs control and RHT4 groups). The morphological study demonstrated myocyte necrosis, vascular damage and cellular inflammatory response throughout the experimental period. The increased cellularity was more intense in the adventitia of the arterioles. As a consequence of myocyte necrosis, there was an early, local, conjunctive stroma collapse with disarray and thickening of the argyrophilic interstitial fibers, followed by scarring. The functional data showed an increased passive myocardial stiffness in the RHT4 group. We conclude that renovascular hypertension induces myocyte and arteriole necrosis. Reparative fibrosis occurred as a consequence of the inflammatory response to necrosis. The mechanical behavior of the isolated papillary muscle was normal, except for an early increased myocardial passive stiffness.

Entities:  

Mesh:

Year:  1997        PMID: 9458975     DOI: 10.1590/s0100-879x1997000900013

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  10 in total

1.  Novel mechanisms for caspase inhibition protecting cardiac function with chronic pressure overload.

Authors:  Misun Park; Stephen F Vatner; Lin Yan; Shumin Gao; Seunghun Yoon; Grace Jung Ah Lee; Lai-Hua Xie; Richard N Kitsis; Dorothy E Vatner
Journal:  Basic Res Cardiol       Date:  2013-01-01       Impact factor: 17.165

2.  The effect of non-antihypertensive doses of angiotensin converting enzyme inhibitor on myocardial necrosis and hypertrophy in young rats with renovascular hypertension.

Authors:  B B Matsubara; L S Matsubara; M Franco; J C Padovani; J S Janicki
Journal:  Int J Exp Pathol       Date:  1999-04       Impact factor: 1.925

3.  Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus.

Authors:  Camila Moreno Rosa; Dijon Henrique Salome Campos; David Rafael Abreu Reyes; Felipe Cesar Damatto; Lucas Yamada Kurosaki; Luana Urbano Pagan; Mariana Janini Gomes; Camila Renata Corrêa; Ana Angelica Henrique Fernandes; Marina Politi Okoshi; Katashi Okoshi
Journal:  Antioxidants (Basel)       Date:  2022-05-17

4.  Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Safia Ogbi; Babak Baban; Jennifer C Sullivan; Takayuki Matsumoto; R Clinton Webb
Journal:  Cardiovasc Res       Date:  2015-04-24       Impact factor: 10.787

5.  Rutin administration attenuates myocardial dysfunction in diabetic rats.

Authors:  Julliano F C Guimaraes; Bruno P Muzio; Camila M Rosa; Andre F Nascimento; Mario M Sugizaki; Ana A H Fernandes; Antonio C Cicogna; Carlos R Padovani; Marina P Okoshi; Katashi Okoshi
Journal:  Cardiovasc Diabetol       Date:  2015-07-17       Impact factor: 9.951

6.  Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.

Authors:  C M Rosa; R Gimenes; D H S Campos; G N Guirado; C Gimenes; A A H Fernandes; A C Cicogna; R M Queiroz; I Falcão-Pires; D Miranda-Silva; P Rodrigues; F R Laurindo; D C Fernandes; C R Correa; M P Okoshi; K Okoshi
Journal:  Cardiovasc Diabetol       Date:  2016-09-01       Impact factor: 9.951

7.  Influence of intermittent fasting on myocardial infarction-induced cardiac remodeling.

Authors:  K Okoshi; M D M Cezar; M A M Polin; J R Paladino; P F Martinez; S A Oliveira; A R R Lima; R L Damatto; S A R Paiva; L A M Zornoff; M P Okoshi
Journal:  BMC Cardiovasc Disord       Date:  2019-05-28       Impact factor: 2.298

8.  Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats.

Authors:  Camila Moreno Rosa; Natasha Priscilla Xavier; Dijon Henrique Campos; Ana Angélica Henrique Fernandes; Marcelo Diarcadia Mariano Cezar; Paula Felippe Martinez; Antonio Carlos Cicogna; Camila Gimenes; Rodrigo Gimenes; Marina Politi Okoshi; Katashi Okoshi
Journal:  Cardiovasc Diabetol       Date:  2013-10-17       Impact factor: 9.951

9.  Low Intensity Physical Exercise Attenuates Cardiac Remodeling and Myocardial Oxidative Stress and Dysfunction in Diabetic Rats.

Authors:  C Gimenes; R Gimenes; C M Rosa; N P Xavier; D H S Campos; A A H Fernandes; M D M Cezar; G N Guirado; A C Cicogna; A H R Takamoto; M P Okoshi; K Okoshi
Journal:  J Diabetes Res       Date:  2015-10-05       Impact factor: 4.011

10.  Effects of Growth Hormone on Cardiac Remodeling During Resistance Training in Rats.

Authors:  Adriana Junqueira; Antônio Carlos Cicogna; Letícia Estevam Engel; Maiara Almeida Aldá; Loreta Casquel de Tomasi; Rogério Giuffrida; Inês Cristina Giometti; Ana Paula Coelho Figueira Freire; Andreo Fernando Aguiar; Francis Lopes Pacagnelli
Journal:  Arq Bras Cardiol       Date:  2015-12-08       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.